| A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response P Dunbar, CL Smith, D Chao, M Salio, D Shepherd, F Mirza, M Lipp, ... The Journal of Immunology 165 (11), 6644-6652, 2000 | 175 | 2000 |
| Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara CL Smith, F Mirza, V Pasquetto, DC Tscharke, MJ Palmowski, P Dunbar, ... The Journal of Immunology 175 (12), 8431-8437, 2005 | 120 | 2005 |
| HLA-A* 0201, HLA-A* 1101, and HLA-B* 0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products V Pasquetto, HH Bui, R Giannino, F Mirza, J Sidney, C Oseroff, ... The Journal of Immunology 175 (8), 5504-5515, 2005 | 115 | 2005 |
| Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence CL Smith, PR Dunbar, F Mirza, MJ Palmowski, D Shepherd, SC Gilbert, ... International journal of cancer 113 (2), 259-266, 2005 | 110 | 2005 |
| High avidity antigen-specific CTL identified by CD8-independent tetramer staining EML Choi, JL Chen, L Wooldridge, M Salio, A Lissina, N Lissin, ... The Journal of Immunology 171 (10), 5116-5123, 2003 | 109 | 2003 |
| Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin T Barth-Jaeggi, P Steinmann, L Mieras, W van Brakel, JH Richardus, ... BMJ open 6 (11), e013633, 2016 | 97 | 2016 |
| Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region L Wooldridge, A Lissina, J Vernazza, E Gostick, B Laugel, SL Hutchinson, ... European journal of immunology 37 (5), 1323-1333, 2007 | 92 | 2007 |
| Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an … L Wooldridge, SL Hutchinson, EM Choi, A Lissina, E Jones, F Mirza, ... The Journal of Immunology 171 (12), 6650-6660, 2003 | 72 | 2003 |
| Innovative tools and approaches to end the transmission of Mycobacterium leprae P Steinmann, SG Reed, F Mirza, TD Hollingsworth, JH Richardus The Lancet Infectious Diseases 17 (9), e298-e305, 2017 | 68 | 2017 |
| The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis P Steinmann, A Cavaliero, ANN Aerts, S Anand, M Arif, S Sao Ay, TM Aye, ... Leprosy review 89 (2), 102, 2018 | 38 | 2018 |
| The Next Generation Scientist program: capacity-building for future scientific leaders in low-and middle-income countries G Pillai, K Chibale, EC Constable, AN Keller, MM Gutierrez, F Mirza, ... BMC Medical Education 18, 1-11, 2018 | 35 | 2018 |
| A comprehensive research agenda for zero leprosy P Steinmann, C Dusenbury, D Addiss, F Mirza, WCS Smith Infectious diseases of poverty 9, 1-7, 2020 | 33 | 2020 |
| Improving hypertension outcome measurement in low-and middle-income countries R Zack, O Okunade, E Olson, M Salt, C Amodeo, R Anchala, O Berwanger, ... Hypertension 73 (5), 990-997, 2019 | 29 | 2019 |
| Pharmacometrics: opportunity for reducing disease burden in the developing world: the case of Africa G Pillai, G Davies, P Denti, JL Steimer, H McIlleron, S Zvada, E Chigutsa, ... CPT: pharmacometrics & systems pharmacology 2 (8), 1-4, 2013 | 28 | 2013 |
| Reimagining leprosy elimination with AI analysis of a combination of skin lesion images with demographic and clinical data RR Barbieri, Y Xu, L Setian, PT Souza-Santos, A Trivedi, J Cristofono, ... The Lancet Regional Health–Americas 9, 2022 | 23 | 2022 |
| Gene expression profiling of immunomagnetically separated cells directly from stabilized whole blood for multicenter clinical trials M Letzkus, E Luesink, S Starck-Schwertz, M Bigaud, F Mirza, N Hartmann, ... Clinical and translational medicine 3, 1-13, 2014 | 14 | 2014 |
| CD8+ T lymphocyte epitopes from the herpes simplex virus type 2 ICP27, VP22 and VP13/14 proteins to facilitate vaccine design and characterization RJ Platt, T Khodai, TJ Townend, HH Bright, P Cockle, L Perez-Tosar, ... Cells 2 (1), 19-42, 2013 | 7 | 2013 |
| Leprosy post-exposure prophylaxis with single-dose rifampicin T Barth-Jaeggi, A Cavaliero, A Aerts, S Anand, M Arif, SS Ay, TM Aye, ... Leprosy Review 90 (4), 356-363, 2019 | 3 | 2019 |
| Programa post-exposición a la profilaxis de la Lepra (LPEP): Actualización y análisis interno P Steinmann, A Cavaliero, A Aerts, S Anand, M Arif, S Sao Ay, ... Fontilles, Rev. leprol, 375-393, 2018 | 1 | 2018 |
| Prolaxis post-exposición para lepra con dosis única de rifampicina: manual para su implementación T Barth-Jaeggi, A Cavaliero, A Aerts, S Anand, M Arif, S Sao Ay, ... Fontilles, Rev. leprol, 263-271, 2020 | | 2020 |
